Medicine composition for treating hyperprolactinemia infertility and application of medicine composition

Abstract

A medicine composition for treating hyperprolactinemia infertility comprises the following active ingredients: radix bupleuri, cortex moutan radicis, selfheal, eclipta, rhizoma pleionis, salvia miltiorrhiza, liquorice, radix cyathulae, Chinese angelica, polygala tenuifolia, pangolin, flos rosae rugosae, prepared rehmannia root, radix paeoniae alba, fructus aurantii, gallnut and lotus stamen. The medicine composition adopts traditional Chinese medicine active ingredients which are wide in source and low in cost, and the medicine composition has a good curative effect, low cost and no toxic or side effects, takes effect quickly, is good news for mass hyperprolactinemia infertility patients and has good application prospects.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to a traditional Chinese medicine composition, in particular to a medicinal composition for treating hyperprolactinemia infertility and an application thereof. Background technique [0002] Hyperprolactinemia (HyPerprolactinemia, HPRL) is caused by factors such as pituitary tumors, postpartum, abortion, hypothyroidism, drugs, and stress acting on the hypothalamus, which interferes with the inhibition of PRL (Prolactin, prolactin) inhibitory factor on the secretion of pituitary PRL. The resulting increase of serum prolactin PRL, a kind of endocrine disease of gonadal axis suppression, women show as abnormal menstruation, amenorrhea, galactorrhea infertility; men can show symptoms such as impotence and less sperm. [0003] Due to the popularization of radioimmunoassay technology, the detection rate of HPRL tends to increase. For example, Tang found in a retrospective analysis of 595 pa...

AI Technical Summary

Problems solved by technology

It has been found in clinical application that the above-mentioned Xianjia granule and other traditional Chinese medicine preparations that have appeared are still unsatisfactory for the treatment of hyperprolactinemia infertility, especially that 10%-15% of women of childbearing age in my country suffer from infertility to varying degrees. Infertility, about half of which is caused by the treatment of hyperprolactinemia-induced infertility. Under the realistic situation, it is more and more to develop a pharmaceutical composition with good curative effect, no side effects and low cost for curing hyperprolactinemia infertility. more urgent

Images